Please use this identifier to cite or link to this item: http://dspace.nuph.edu.ua/handle/123456789/26778
Title: Administration of «CORVITIN®» as an off-label agent for pharmacological correction of metabolic syndrome
Authors: Калько, К. О.
Дроговоз, С. М.
Міщенко, О. Я.
Комісаренко, А. М.
Комісаренко, М. А.
Бондарев, Є. В.
Keywords: Corvitin;metabolic syndrome;off-label
Issue Date: 2021
Bibliographic description (Ukraine): Administration of «CORVITIN®» as an off-label agent for pharmacological correction of metabolic syndrome / K. O. Kalko, S. M. Drogovoz, O. Ya. Mishchenko, M. A. Komisarenko, A. M. Komissarenko, Y. V. Bondariev, Moeen Dababneh // Проблеми ендокринної патології. - 2021. - № 1. - С. 97-102.
Abstract: Nowadays metabolic syndrome is a noninfectious pandemic of the ХХІ century. Therefore search of effective pharmacological agents for its pharmacological correction is an urgent issue of modern medicine and pharmaceutical community. At the same time, today off-label administration of medicines (for an unapproved indication) has become widely used. This approach is based on new determined pharmacological effects of drugs unknown before. These effects were not studied during the primary development of a pharmacological agent, but they were found after its registration and appearance at the pharmaceutical market.
URI: http://dspace.nuph.edu.ua/handle/123456789/26778
ISSN: 2518-1432
2227-4782
Appears in Collections:Наукові публікації кафедри клінічної фармакології ІПКСФ

Files in This Item:
File Description SizeFormat 
ADMINISTRATION OF «CORVITIN®.pdf306,03 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.